Wave Life Sciences Ltd Live Stock Price Today, Share Analysis and Chart

Name: Wave Life Sciences Ltd.: Is Infosys Ltd. worth buying?
Item: Wave Life Sciences Ltd.
Rating: 0.926861125
Author: Trendlyne DVM scores

Momentum Trap

about

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, com...

7.18 -0.06 (-0.83%)

66.96% Fall from 52W High

2.5M

XNAS Volume

XNAS 08 May, 2026 4:19 PM (EDT)

Board Meeting

The board meeting for Wave Life Sciences Ltd is scheduled for today, for the purpose of WAVE Life Sciences Ltd First Quarter Earnings Results for 2026 See details

Low Financial Strength

11.1 / 100

Expensive Valuation

13.7 / 100

Technically Neutral

38.3 / 100

Momentum Trap These stocks have weak financials and expensive valuation. Medium technical scores may weaken. Investors should exercise caution View Similar Embed DVM

1Yr Price target upside is 209%

16 analysts

Wave Life Sciences Ltd Live Price Chart

Switch to TradingView

Loading Fundamental data..

Loading data..

Wave Life Sciences Ltd Live Stock Price Today, Share Analysis and Chart

WAVE Life Sciences Ltd is a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines also known as oligonucleotides, targeting ribonucleic acid (RNA), to transform human health. RNA medicines platform, PRISM, com...

66.96% Fall from 52W High

SWOT Analysis

Wave Life Sciences Ltd Live Price Chart